Genetic heterogeneity for Her2 accounts for a significant percentage of breast cancers changing Her2 status following implementation of the 2013 CAP/ASCO HER2 reporting guidelines

被引：0
|
作者：
Estrada, Monica V. [1 ]
Giltnane, Jena M. [1 ]
Wheeler, Ferrin C. [1 ]
Yenamandra, Ashwini [1 ]
Abramson, Vandana [1 ]
Mayer, Ingrid A. [1 ]
Means, Julie [1 ]
Rexer, Brent [1 ]
Meszoely, Ingrid M. [1 ]
Sanders, Melinda E. [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-06-32
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] HER2 Results in Breast Carcinomas Following Updated ASCO/CAP Recommendation Guidelines
    Jones-Ragle, Ashley
    Reisenbichler, Emily
    MODERN PATHOLOGY, 2015, 28 : 49A - 49A
  • [22] Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines
    Xu, Fang-Ping
    Wang, Kun
    Xu, Jie
    Chen, Jie
    Zhang, Yi-Fang
    Wu, Hong-Mei
    Zhang, Ming-Hui
    Long, Xiao-Xu
    Luo, Xin-Lan
    Zhang, Ke-Ping
    Lin, Dan-Yi
    Liu, Yan-Hui
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (03) : 757 - 764
  • [23] Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines
    Fang-Ping Xu
    Kun Wang
    Jie Xu
    Jie Chen
    Yi-Fang Zhang
    Hong-Mei Wu
    Ming-Hui Zhang
    Xiao-Xu Long
    Xin-Lan Luo
    Ke-Ping Zhang
    Dan-Yi Lin
    Yan-Hui Liu
    Breast Cancer Research and Treatment, 2017, 166 : 757 - 764
  • [24] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
    Jensen, Steffen Grann
    Thomas, Peter Engel
    Christensen, Ib Jarle
    Balslev, Eva
    Hansen, Alastair
    Hogdall, Estrid
    APMIS, 2020, 128 (11) : 573 - 582
  • [25] Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+Invasive Breast Cancer
    Yamada, Mai
    Kubo, Makoto
    Yamamoto, Hidetaka
    Yamashita, Nami
    Kai, Masaya
    Zaguirre, Karen
    Kaneshiro, Kazuhisa
    Shimazaki, Akiko
    Hayashi, Saori
    Kawaji, Hitomi
    Mori, Masaki
    Oda, Yoshinao
    Nakamura, Masafumi
    ANTICANCER RESEARCH, 2021, 41 (08) : 4143 - 4149
  • [26] HER2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines
    McLemore, Lauren E.
    Albarracin, Constance T.
    Gruschkus, Stephen K.
    Bassett, Roland L., Jr.
    Wu, Yun
    Dhamne, Sagar
    Yiml, Isaiah
    Lin, Kevin
    Bedrosian, Isabelle
    Sneigel, Nour
    Chen, Hui
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (01) : 95 - 104
  • [27] HER2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines
    Lauren E. McLemore
    Constance T. Albarracin
    Stephen K. Gruschkus
    Roland L. Bassett
    Yun Wu
    Sagar Dhamne
    Isaiah Yim
    Kevin Lin
    Isabelle Bedrosian
    Nour Sneige
    Hui Chen
    Breast Cancer Research and Treatment, 2021, 187 : 95 - 104
  • [28] HER2 genetic heterogeneity in breast carcinoma
    Oehlschlegel, Christian
    Zahel, Katharina
    Kradolfer, Doris
    Hell, Margreth
    Jochum, Wolfram
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (12) : 1112 - 1116
  • [29] The Impact of 2013 ASCO/CAP Guidelines on the Breast Cancer Her2/Neu FISH Results
    Zhang, Songlin
    Wang, Xiaohong
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 149 : S144 - S144
  • [30] Analysis of molecular subtypes for the increased HER2 equivocal cases caused by application of the updated 2013 ASCO/CAP HER2 testing guidelines in breast cancer
    Lei Guo
    Pei Yuan
    Jing Zhang
    Yun Ling
    Wenbin Li
    Bohui Zhao
    Jianming Ying
    Lixue Xuan
    Breast Cancer Research and Treatment, 2017, 166 : 77 - 84
12345